Upstate Active Clinical Trials
Study Title:
High Dose Cyclophosphamide, Thiotepa & Etoposide Followed by Autologous Hematopoietic Stem Cell Transplantation (Intermediate & High Grade).What is the purpose of the study? (in Layman's terms, please describe the study)
To provide autologous transplantation for patients with Non-Hodgkins's Lymphoma.Upstate Institutional Review Board (IRB) Number:
229996Study/Protocol ID:
BMT 9204Study Phase:
N/APatient Age Group:
AdultsPrincipal Investigator:
Dorothy C Pan, MDWho is eligible?
Diagnosis of non-hodgkin's disease, acceptable laboratory values, HIV negative, no serious or uncontolled organ dysfunction.What is involved if I participate?
- How long is the study?
Inpatient stay approximately 21 days, followed for lifetime. - Is transportation provided or reimbursed?
No - Is parking provided or reimbursed?
No - What tests and procedures are involved?
Detailed history & physical to determine eligibility, laboratory tests, x-rays/scans, as necessary, bone marrow biopsy & aspirate as necessary, laboratory tests during hospital admission, dental clearance prior to transplant.
Where will the study take place?
SUNY Upstate Medical University,Syracuse, NYOther Information:
Who can I contact for more information?
Name: Shramika Pokharel, MBBS, MPH
Phone: 315-464-8271
Email: pokhares@upstate.edu